Sr. Director, US Value

Who We Are

BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.

Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we've produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.

About Commercial
Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin's commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific.

Summary:
The Market Access Strategy Sr. Director will lead US value, access, and reimbursement strategy development to ensure optimal patient access, coverage, reimbursement for BioMarin's Enzyme Therapies business unit. This individual will play a critical role in aligning cross functional teams, managing payer and channel strategies, and shaping the external market access environment to support product value and commercial success. This position works closely with multiple stakeholders within the commercial, medical affairs, and key corporate functions. This position reports to the Vice President of US Market Access.

This position drives strategies to ensure market access success by objectively evaluating the US coverage and reimbursement environment and providing subject matter expertise to influence commercial planning and market entry plans. The position identifies access issues and opportunities, and collaborates with commercial/cross-functional teams that address them.

Responsibilities:

• Develop and execute U.S. market access strategies to support product launches and ongoing commercialization.
• Lead payer engagement strategy, including national and regional commercial payers, PBMS, Medicare and Medicaid
• Partner with pricing, HEOR, government affairs, patients services and field access teams to develop compelling value propositions and evidence plans.
• Oversee the development of access-related tools and resources (AMCP dossiers, value decks, coverage policies)
• Collaborate closely with the sales, marketing, medical affairs, and legal teams to ensure alignment on strategy and execution.
• Monitor policy, reimbursement, and pricing landscape and assess implications for the business.
• Support contracting strategy development and assist with negotiations as needed.
• Manage relationships with external vendors, consultants and payer advisors.
• Analyze access and utilization data to inform strategy and measure performance.
• Actively serve as US market access SME/voice for the enzyme therapies business unit in the commercial organization

Required Experience/Skills:

• Minimum 10+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions.
• Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape.
• Deep understanding of health policy & health system environment for transformative and rare therapies.
• Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues.
• Excellent communication, collaboration, influence, strategic and analytical skills are required.
• Ability to lead cross-functional teams in a fast-paced, dynamic environment.

Preferred Qualifications:

• US launch experience in specialty therapeutics (Oncology, rare disease, immunology)
• Experience with Medicare Part B/D, Medicaid and commercial payers
• Familiarity with ICER, QALY models, and evidence-based value frameworks
• Understanding of value-based contracting and innovative reimbursement models

Education:

• Bachelors, preferably in life sciences or economics
• MBA or MPH, preferred

Additional:

• This position is physically located in BioMarin's corporate offices in San Rafael, CA, with travel approximately 25%
• This position has no direct reports

Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

The salary range for this position is: $221,900 to $ BioMarin considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans.

For additional benefits information, visit:

• Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.